Home Other Building Blocks 1H-Indene-1,3(2H)-dione, 2-(4-methoxyphenyl)-

1H-Indene-1,3(2H)-dione, 2-(4-methoxyphenyl)-

CAS No.:
117-37-3
Catalog Number:
AG000DHN
Molecular Formula:
C16H12O3
Molecular Weight:
252.2647
Pack Size
Purity
Availability
Location
Price(USD)
Quantity
  
1g
≥ 98% (TLC)
1 week
United States
$96
- +
5g
≥ 98% (TLC)
1 week
United States
$213
- +
Product Description
Catalog Number:
AG000DHN
Chemical Name:
1H-Indene-1,3(2H)-dione, 2-(4-methoxyphenyl)-
CAS Number:
117-37-3
Molecular Formula:
C16H12O3
Molecular Weight:
252.2647
MDL Number:
MFCD00176194
IUPAC Name:
2-(4-methoxyphenyl)indene-1,3-dione
InChI:
InChI=1S/C16H12O3/c1-19-11-8-6-10(7-9-11)14-15(17)12-4-2-3-5-13(12)16(14)18/h2-9,14H,1H3
InChI Key:
XRCFXMGQEVUZFC-UHFFFAOYSA-N
SMILES:
COc1ccc(cc1)C1C(=O)c2c(C1=O)cccc2
EC Number:
204-186-6
UNII:
S747T1ERAJ
NSC Number:
759629
Properties
Complexity:
344  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
252.079g/mol
Formal Charge:
0
Heavy Atom Count:
19  
Hydrogen Bond Acceptor Count:
3  
Hydrogen Bond Donor Count:
0
Isotope Atom Count:
0
Molecular Weight:
252.269g/mol
Monoisotopic Mass:
252.079g/mol
Rotatable Bond Count:
2  
Topological Polar Surface Area:
43.4A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
2.9  
Literature
Title Journal
Antithrombotic medication for cardioembolic stroke prevention. Stroke research and treatment 20110101
Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis. Bioorganic & medicinal chemistry letters 20101101
Prediction of pharmacological and xenobiotic responses to drugs based on time course gene expression profiles. PloS one 20090101
Microsphere-based protease assays and screening application for lethal factor and factor Xa. Cytometry. Part A : the journal of the International Society for Analytical Cytology 20060501
Anticoagulation with anisindione in a patient with a warfarin-induced skin eruption. Pharmacotherapy 20030401
Anticoagulation with anisindione in patients who are intolerant of warfarin. American journal of hematology 19940601
Hypolipidemic activity of indan-1,3-dione derivatives in rodents. Journal of medicinal chemistry 19851101
Evaluation of anticoagulant therapy with anisindione (miradon). Canadian Medical Association journal 19590515
Properties